Manning Meredith bought UNCY

October 28, 2026 · Form 4 insider transaction

Manning Meredith bought 3,350 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
3,350
Price
$0.00
Total value
N/A
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 28, 2026
Filing dateOctober 29, 2026
Shares owned after3,350
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents grant of restricted stock units payable solely in common stock of the Issuer. 837 shares vest upon grant and 209 vest monthly over 12 months beginning Nov. 1, 2026, subject to the Reporting Person's continued service with the Issuer.

View the original Form 4 on SEC EDGAR